Patient presents with signs and symptoms consistent with Thyroid Eye Disease (TED), also known as Graves' ophthalmopathy or Graves' orbitopathy.  Clinical presentation includes [Insert specific findings e.g., proptosis, eyelid retraction, diplopia, restricted extraocular motility, conjunctival injection, chemosis, periorbital edema, corneal exposure].  Patient reported [Insert patient-reported symptoms e.g., eye irritation, dryness, grittiness, photophobia, pain, blurred vision, pressure sensation].  Medical history significant for [Insert relevant medical history e.g., Graves' disease, hyperthyroidism, hypothyroidism, thyroid surgery, radioactive iodine treatment, smoking history].  Current medications include [List current medications].  Visual acuity measured [Insert visual acuity for both eyes].  Intraocular pressure (IOP) is [Insert IOP readings].  Hertel exophthalmometry measurements are [Insert measurements].  Clinical Activity Score (CAS) is [Insert CAS score].  Based on the clinical findings and patient history, the diagnosis of Thyroid Eye Disease is confirmed.  Differential diagnoses considered include [Insert relevant differential diagnoses e.g., orbital pseudotumor, orbital cellulitis, dacryoadenitis].  Treatment plan includes [Specify treatment plan e.g., artificial tears, lubricating ointments, smoking cessation counseling, selenium supplementation, glucocorticoids, orbital decompression surgery, strabismus surgery, teprotumumab].  Patient education provided regarding the disease process, treatment options, and potential complications.  Follow-up scheduled in [Specify timeframe] to monitor disease progression and treatment response.  ICD-10 code H05.10 (Thyroid ophthalmopathy, bilateral) or H05.11 (Thyroid ophthalmopathy, unilateral, right) or H05.12 (Thyroid ophthalmopathy, unilateral, left) is applicable.  CPT codes for relevant examinations, imaging studies, and procedures will be documented separately.